MGF Research# MGF research originates primarily from the laboratory of Geoffrey Goldspink at University College London: Discovery and characterization : First described in the late 1990s as a mechanically sensitive IGF-1 splice variant in rabbit and human skeletal muscle Satellite cell activation : Demonstrated ability to activate quiescent satellite cells in culture, with evidence for IGF-1R-independent signaling Cardiac applications : Expression of IGF-1Ec documented in cardiac muscle following myocardial infarction, with preclinical evidence for cardioprotective effects Neuroprotection : MGF expression detected in brain tissue following ischemic injury, with preliminary evidence for neuronal survival effects Aging research : Impaired MGF upregulation documented in elderly subjects after exercise, suggesting a mechanism for age-related decline in regenerative capacity MGF remains entirely preclinical, with no human clinical trials

Approved recombinant IGF-1 products such as mecasermin are not the same as PEG-MGF, but their labels and regulator summaries show that IGF-1 pathway drugs can have clinically important risks and specialist-use restrictions [19]
-46% HOT PROMO Ultra Premium Whey Protein Build 12.96 / 25.35
After: Month 2-3 shows improved radiance and texture
Once inside the mitochondrial matrix, carnitine palmitoyltransferase II (CPT II) converts fatty acyl-carnitine back into fatty acyl-CoA, allowing beta-oxidation to proceed in experimental systems